Hosted on MSN11h
Organon (NYSE:OGN) Exceeds Q4 Expectations But Full-Year Sales Guidance Misses Expectations SignificantlyPharmaceutical company Organon (NYSE:OGN) reported Q4 CY2024 results , but sales were flat year on year at $1.59 billion. On ...
We recently published a list of 10 Best Widow and Orphan Stocks To Invest In. In this article, we are going to take a look at ...
In a new policy draft, the government set a target of having at least 30 percent of executive positions at companies listed on the Tokyo Stock Exchange Prime Market be filled by women by 2030. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results